← All Sponsors
SPONSOR

Biostar Pharma, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 2

Biostar Pharma, Inc. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including HER2-negative Breast Cancer Patients With Brain Metastases.

The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Biostar Pharma, Inc.

How many clinical trials has Biostar Pharma, Inc. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Biostar Pharma, Inc., of which 1 are actively recruiting participants. These trials cover conditions including HER2-negative Breast Cancer Patients With Brain Metastases. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Biostar Pharma, Inc. research focus on?
Biostar Pharma, Inc. clinical trials span HER2-negative Breast Cancer Patients With Brain Metastases. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Biostar Pharma, Inc. clinical trial?
To participate in a Biostar Pharma, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Biostar Pharma, Inc. trials with current recruitment status updated daily.

Clinical Trials by Biostar Pharma, Inc.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology